Add BrightSurf on Google Email

Less is more: Not placing a drain improves distal pancreatectomy outcomes

A study published in Lancet Gastroenterology & Hepatology found that not placing a drain during distal pancreatectomy surgery improves patient outcomes. The study, involving 282 patients across ten Dutch and two Italian hospitals, demonstrated a significant reduction in postoperative pancreatic leaks and overall morbidity.

SourceAmsterdam University Medical Center·JournalThe Lancet Gastroenterology & Hepatology·TypeRandomized controlled/clinical trial·DateMar 15, 2024

Next generation stool DNA test has best detection rate of noninvasive colorectal cancer screening tools

A new study published in New England Journal of Medicine found that a next generation multi-target stool DNA colorectal cancer screening test detects 94 percent of colorectal cancers, outperforming other noninvasive tests. The test has the best detection rate for both colorectal cancer and advanced precancerous polyps.

SourceRegenstrief Institute·JournalNew England Journal of Medicine·DateMar 13, 2024

AGA announces 12-point plan to improve the care of all patients with inflammatory bowel disease (IBD)

The American Gastroenterological Association has proposed a 12-point plan to enhance IBD care in the US, focusing on insurer-mandated barriers such as prior authorization and step therapy. The plan aims to improve treatment access and quality for over three million Americans living with IBD.

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·TypeSystematic review·DateFeb 28, 2024

Traditional regression approach outperformed machine learning algorithms in predicting optimal surgical method in patients with submucosal tumors.

A study compared traditional logistic regression models and machine learning algorithms to predict the best surgical technique for patients with submucosal tumors. The traditional regression approach was found to outperform ML algorithms, with morphology ranking as the highest contributor to prediction accuracy.

SourceKeAi Communications Co., Ltd.·JournalGastroenterology & Endoscopy·TypeData/statistical analysis·DateFeb 27, 2024

Study finds black children in UK at four times greater risk of complications following emergency appendicitis surgery compared with white children

A UK study published in Anaesthesia found that black children are at a significantly higher risk of postoperative complications following emergency appendicitis surgery, with a four-fold greater risk compared to white children. The study also identified other risk factors for complications, including pre-existing medical conditions and...

SourceAAGBI·JournalAnaesthesia·DateFeb 22, 2024

AGA now recommends fecal microbiota transplant for the majority of recurrent C. diff patients

The American Gastroenterological Association recommends fecal microbiota transplant (FMT) as a safe and effective treatment for most patients with recurrent Clostridioides difficile infection. FMT offers hope to patients suffering from debilitating C. diff, enabling them to lead happy and healthy lives.

SourceAmerican Gastroenterological Association·JournalGastroenterology·TypeSystematic review·DateFeb 21, 2024

Cleveland Clinic and University of Western Ontario awarded $4.9 million from the Helmsley Charitable Trust to build Crohn’s disease and ileostomy research consortium

A new consortium, co-led by Florian Rieder, MD, and Vipul Jairath, MD, will create clinical care pathways toward drug development and improve disease management for patients with Crohn's disease and permanent ileostomy. The EndO-trial Consortium aims to develop effective drugs and measure treatment outcomes using patient-reported outco...

Narrow-band imaging at low magnification can detect lesions overlooked by white-light imaging

A recent study published in Gastroenterology & Endoscopy found that narrow-band imaging at low magnification can detect lesions missed by white-light imaging. Annual endoscopic examinations using LM-NBI revealed a threefold higher detection rate of neoplastic lesions compared to conventional magnifying endoscopy.

SourceKeAi Communications Co., Ltd.·JournalGastroenterology & Endoscopy·TypeObservational study·DateDec 17, 2023

Potential of forsythiae fructus in mitigating chemotherapy-induced gastrointestinal inflammation and nausea

Researchers found that Forsythiae Fructus attenuates cisplatin-induced cytotoxicity in cells by inhibiting NLRP3/caspase-1/GSDMD mediated pyroptosis, suggesting its potential as a therapeutic approach against chemotherapy-induced gastrointestinal inflammation and nausea.

SourceKeAi Communications Co., Ltd.·JournalJournal of Holistic Integrative Pharmacy·TypeExperimental study·DateDec 12, 2023

If a piece of Turkey gets stuck in your throat this Christmas, there is no point in trying to free it with Cola

A study published in the BMJ Christmas Issue investigated the effectiveness of cola in loosening stuck food in the oesophagus. The results show no significant improvement, with only 61% of patients experiencing relief on their own. Cola use was found to have no side effects or complications.

SourceAmsterdam University Medical Center·JournalThe BMJ·TypeRandomized controlled/clinical trial·DateDec 11, 2023

First comprehensive guideline on using biomarkers for monitoring Crohn’s disease

The American Gastroenterological Association released a new guideline recommending the use of biomarkers to help manage Crohn’s disease. Biomarkers such as C-reactive protein and fecal calprotectin can measure levels of inflammation, helping doctors assess disease activity and guide treatment decisions.

SourceAmerican Gastroenterological Association·JournalGastroenterology·TypeSystematic review·DateNov 17, 2023

AGA does not endorse all patients stopping popular diabetes and weight loss drugs prior to endoscopy

The American Gastroenterological Association suggests a balanced approach when treating patients on GLP-1 RAs undergoing endoscopic procedures. AGA recommends proceeding with the procedure as planned for patients who followed standard pre-procedure fasting instructions and do not have symptoms suggesting retained gastric contents.

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·TypeSystematic review·DateNov 7, 2023

A joint research team from South Korea and the United States has identified a new gene classification system for gastric cancer

A joint research team from South Korea and the US has developed a new genetic classification system for gastric cancer, identifying six consensual genomic subtypes (CGSs) with distinct characteristics. The study suggests potential treatments for each subtype, including immunotherapy and targeted therapies.

SourceKorea University College of Medicine·JournalMolecular Cancer·TypeRandomized controlled/clinical trial·DateNov 6, 2023

Researchers use AI to predict challenging behaviors common in profound autism

A study found that gastrointestinal and sleep issues may be connected to self-injury and aggression in adolescents diagnosed with profound autism. The researchers discovered a possible connection between these health issues and future challenging behaviors, predicting next-day behavior with over 80% accuracy.

SourceRensselaer Polytechnic Institute·JournalJournal of Personalized Medicine·TypeData/statistical analysis·DateNov 6, 2023

Risk of serious infection even in low-active IBD

Research at the University of Gothenburg found that even low-active IBD patients have a higher risk of serious infections due to microscopic intestinal inflammation. Achieving a fully healed intestinal mucosa may reduce this risk, contributing to lower morbidity and mortality in IBD patients.

SourceUniversity of Gothenburg·JournalClinical Gastroenterology and Hepatology·TypeObservational study·DateNov 1, 2023

Children’s Hospital Los Angeles researchers develop clinical tool to predict if a child in acute liver failure will need a transplant

Researchers at Children's Hospital Los Angeles have developed a novel app called the CHALF score to predict if a child with acute liver failure needs a transplant. The tool assesses liver failure risk on a scale of 5-60 and has been shown to accurately predict patient outcomes.

SourceChildren's Hospital Los Angeles·JournalTransplantation·TypeComputational simulation/modeling·DateOct 24, 2023

Turmeric may be as good for treating indigestion as drug to curb excess stomach acid

A study of 151 patients with functional dyspepsia found that turmeric's curcumin was as effective as omeprazole in reducing symptoms after 28 days. Patients who took the combination treatment showed stronger improvements after 56 days, suggesting curcumin may be a viable alternative to conventional drugs.

SourceBMJ Group·JournalBMJ Evidence-Based Medicine·TypeRandomized controlled/clinical trial·DateSep 11, 2023

Study sheds light on cellular interactions that lead to liver transplant survival

Researchers identify key protein interactions that control the body's immune response during liver transplantation, leading to improved transplant survival rates. The study found that a specific communication pathway between CEACAM1 and TIM-3 proteins plays a crucial role in controlling the immune response.

SourceUniversity of California - Los Angeles Health Sciences·JournalGastroenterology·TypeExperimental study·DateJul 19, 2023

Even with insurance, many patients with diabetes turn to GoFundMe to offset high cost of care

A study found that even insured patients with diabetes use crowdfunding platforms like GoFundMe to cover excess medical expenses, including uncovered co-pays and life-saving care. Researchers urge policymakers to consider these needs when developing affordable diabetes care policies.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeData/statistical analysis·DateJun 12, 2023

Study may explain why high-sugar diets can worsen IBD

A new study suggests that high-sugar diets can exacerbate inflammatory bowel disease (IBD) symptoms by disrupting the colon's lining renewal process. The research found that a high-sugar diet led to impaired cell division and altered metabolic pathways in mice, resulting in faster gut damage.

SourceUniversity of Pittsburgh·JournalCellular and Molecular Gastroenterology and Hepatology·TypeExperimental study·DateMay 22, 2023

Ingestible electroceutical capsule shows promise for treating gastrointestinal conditions

Researchers from Brigham and Women's Hospital developed an ingestible capsule, known as the FLASH system, which electronically stimulates key hunger hormone ghrelin in pigs. The system has potential applications for treating gastrointestinal disorders and is a promising alternative to traditional treatments.

SourceBrigham and Women's Hospital·JournalScience Robotics·TypeObservational study·DateApr 26, 2023

Study finds stool transplants more effective than antibiotics for treating recurring, life-threatening gut infections

A new Cochrane Review found that stool transplantation can increase the number of people recovering from Clostridioides difficile (C. diff) infection by 77%, compared to 40% with standard antibiotic treatment. The study also showed a decrease in side effects with stool transplantation.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateApr 24, 2023

HKUMed finds global prevalence of H. pylori infection steadily declining over 40 years Combination of antibiotics in treating H. pylori could alter the virus community in the gut

The study found that the global prevalence of H. pylori infection declined from 58.2% in 1980-1990 to 43.1% in 2011-2022, with a decline of about 0.39-0.83% per year. Despite this decline, over 40% of the adult population still carries the infection, posing a significant burden on healthcare systems worldwide.

SourceThe University of Hong Kong·JournalThe Lancet·TypeExperimental study·DateApr 24, 2023

Patients with IBD at higher risk of lymphoma

Patients with inflammatory bowel disease (IBD) are at a higher risk of developing lymphoma, particularly those with Crohn's disease. The risk is driven by both the disease activity and treatment, including immunomodulating drugs.

SourceKarolinska Institutet·JournalClinical Gastroenterology and Hepatology·TypeObservational study·DateApr 13, 2023

American Foregut Society white paper recommends expanding endoscopic classification of esophogastric junction integrity beyond hill grade

The American Foregut Society has proposed a new classification system to assess esophagogastric junction (EGJ) integrity, expanding beyond the Hill grade. The new classification takes into account EGJ disruption and hiatus hernia extent, providing a more comprehensive understanding of GERD.

SourceSAGE·JournalForegut The Journal of the American Foregut Society·TypeSystematic review·DateMar 3, 2023

CU School of Medicine researchers part of national team that identified a new dietary approach to treatment for eosinophilic esophagitis

A new dietary approach has been identified to treat eosinophilic esophagitis by eliminating only dairy products, showing similar effectiveness to the standard six-food elimination diet. This breakthrough study led by CU School of Medicine researchers offers a more patient-friendly treatment option with fewer drawbacks.

SourceUniversity of Colorado Anschutz Medical Campus·JournalThe Lancet Gastroenterology & Hepatology·DateFeb 28, 2023

Forgoing one food treats eosinophilic esophagitis as well as excluding six

A new study found that eliminating animal milk alone from the diet of adults with eosinophilic esophagitis is just as effective as eliminating six common foods, including animal milk, eggs, wheat, soy, fish, and nuts. The one-food elimination diet may be a more manageable option for people with EoE.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalThe Lancet Gastroenterology & Hepatology·DateFeb 27, 2023

Vibrating capsule doubles the ability for constipation sufferers to poop without drugs

A vibrating capsule designed to stimulate the colon has been shown to double the number of complete spontaneous bowel movements in adults with debilitating chronic constipation. The device, which is not a drug and works directly in the colon, showed significant improvement in symptoms such as straining and stool consistency.